全文获取类型
收费全文 | 127154篇 |
免费 | 10804篇 |
国内免费 | 3236篇 |
专业分类
耳鼻咽喉 | 526篇 |
儿科学 | 1670篇 |
妇产科学 | 964篇 |
基础医学 | 5350篇 |
口腔科学 | 1399篇 |
临床医学 | 12528篇 |
内科学 | 13927篇 |
皮肤病学 | 1836篇 |
神经病学 | 5499篇 |
特种医学 | 1625篇 |
外国民族医学 | 7篇 |
外科学 | 5545篇 |
综合类 | 22020篇 |
现状与发展 | 3篇 |
一般理论 | 9篇 |
预防医学 | 10540篇 |
眼科学 | 1168篇 |
药学 | 42056篇 |
191篇 | |
中国医学 | 8221篇 |
肿瘤学 | 6110篇 |
出版年
2024年 | 121篇 |
2023年 | 2091篇 |
2022年 | 3145篇 |
2021年 | 4789篇 |
2020年 | 5023篇 |
2019年 | 4853篇 |
2018年 | 4723篇 |
2017年 | 5174篇 |
2016年 | 5154篇 |
2015年 | 5089篇 |
2014年 | 10945篇 |
2013年 | 14140篇 |
2012年 | 9724篇 |
2011年 | 9573篇 |
2010年 | 7412篇 |
2009年 | 5938篇 |
2008年 | 5474篇 |
2007年 | 5364篇 |
2006年 | 4630篇 |
2005年 | 3879篇 |
2004年 | 3169篇 |
2003年 | 2803篇 |
2002年 | 2207篇 |
2001年 | 2076篇 |
2000年 | 1690篇 |
1999年 | 1368篇 |
1998年 | 1116篇 |
1997年 | 1011篇 |
1996年 | 821篇 |
1995年 | 786篇 |
1994年 | 693篇 |
1993年 | 583篇 |
1992年 | 598篇 |
1991年 | 519篇 |
1990年 | 412篇 |
1989年 | 363篇 |
1988年 | 335篇 |
1987年 | 321篇 |
1986年 | 272篇 |
1985年 | 384篇 |
1984年 | 404篇 |
1983年 | 327篇 |
1982年 | 322篇 |
1981年 | 275篇 |
1980年 | 211篇 |
1979年 | 204篇 |
1978年 | 172篇 |
1977年 | 113篇 |
1976年 | 127篇 |
1975年 | 116篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
《Journal of neonatal nursing : JNN》2022,28(3):148-154
The discussion paper will focus on continuity of care relating to previous NZ research, specifically to transitioning complex preterm infants from NICU to home based on parent experiences, and on the practice developments that have occurred, to ensure optimal health outcomes. Previous NZ research discovered parent desire a consistent service delivery for the entire transition journey from NICU and at home.An informative and comprehensive opportunity has occurred for reflective professional practice, evaluation, development and implementation which have transpired in positive change through innovative practice developments and support change implementation in Wellington, NZ. This has resulted in the articulation of a model of care that has both embraced and integrated parental desires for a continuity of care process for complex preterm infants. This has been achieved by having the same Discharge Facilitator/Key Case Manager present within the NICU and external to the NICU for Home-based infants for the entire transition journey.The paper will focus and emphasis additional practice development changes and furthermore, will present a real purpose, for other countries to learn of such practice developments that have exemplified a celebratory success for families of Wellington, NZ. 相似文献
3.
《Research in social & administrative pharmacy》2022,18(8):3284-3289
BackgroundAdverse drug reactions (ADRs) and adverse drug events (ADEs) in older people contribute to a significant proportion of hospital admissions and are common following discharge. Effective interventions are therefore required to combat the growing burden of preventable ADRs. The Prediction of Hospitalisation due to Adverse Drug Reactions in Elderly Community Dwelling Patients (PADR-EC) score is a validated risk score developed to assess the risk of ADRs in people aged 65 years and older and has the potential to be utilised as part of an intervention to reduce ADRs.ObjectivesThis trial was designed to investigate the effectiveness of an intervention to reduce ADR incidence in older people and to obtain further information about ADRs and ADEs in the 12–24 months following hospital discharge.MethodsThe study is an open-label randomised-controlled trial to be conducted at the Royal Hobart Hospital, a 500-bed public hospital in Tasmania, Australia. Community-dwelling patients aged 65 years and older with an unplanned overnight admission to a general medical ward will be recruited. Following admission, the PADR-EC ADR score will be calculated by a research pharmacist, with the risk communicated to clinicians and discussed with participants. Following discharge, nominated general practitioners and community pharmacists will receive the risk score and related medication management advice to guide their ongoing care of the patient. Follow-up with participants will occur at 3 and 12 and 18 and 24 months to identify ADRs and ADEs. The primary outcome is moderate-severe ADRs at 12 months post-discharge, and will be analysed using the cumulative incidence proportion, survival analysis and Poisson regression.SummaryIt is hypothesised that the trial will reduce ADRs and ADEs in the intervention population. The study will also provide valuable data on post-discharge ADRs and ADEs up to 24 months post-discharge. 相似文献
4.
《Vaccine》2022,40(27):3721-3726
We initiated a randomized, placebo-controlled, phase 1/2 trial to evaluate the safety and immunogenicity of the S-268019-b recombinant protein vaccine, scheduled as 2 intramuscular injections given 21 days apart, in 60 randomized healthy Japanese adults. We evaluated 2 regimens of the S-910823 antigen (5 μg [n = 24] and 10 μg [n = 24]) with an oil-in-water emulsion formulation and compared against placebo (n = 12). Reactogenicity was mild in most participants. No serious adverse events were noted. For both regimens, vaccination resulted in robust IgG and neutralizing antibody production at days 36 and 50 and predominant T-helper 1-mediated immune reaction, as evident through antigen-specific polyfunctional CD4+ T-cell responses with IFN-γ, IL-2, and IL-4 production on spike protein peptides stimulation. Based on the interim analysis, the S-268019-b vaccine is safe, produces neutralizing antibodies titer comparable with that in convalescent serum from COVID-19-recovered patients. However, further evaluation of the vaccine in a large clinical trial is warranted. 相似文献
5.
《European journal of surgical oncology》2022,48(12):2414-2423
IntroductionTextbook outcome (TO) is a composite outcome measure covering the surgical care process in a single outcome measure. TO has an advantage over single outcome parameters with low event rates, which have less discriminating impact to detect differences between hospitals. This study aimed to assess factors associated with TO, and evaluate hospital and network variation after case-mix correction in TO rates for liver surgery.MethodsThis was a population-based retrospective study of all patients who underwent liver resection for malignancy in the Netherlands in 2019 and 2020. TO was defined as absence of severe postoperative complications, mortality, prolonged length of hospital stay, and readmission, and obtaining adequate resection margins. Multivariable logistic regression was used for case-mix adjustment.Results2376 patients were included. TO was accomplished in 1380 (80%) patients with colorectal liver metastases, in 192 (76%) patients with other liver metastases, in 183 (74%) patients with hepatocellular carcinoma and 86 (51%) patients with biliary cancers. Factors associated with lower TO rates for CRLM included ASA score ≥3 (aOR 0.70, CI 0.51–0.95 p = 0.02), extrahepatic disease (aOR 0.64, CI 0.44–0.95, p = 0.02), tumour size >55 mm on preoperative imaging (aOR 0.56, CI 0.34–0.94, p = 0.02), Charlson Comorbidity Index ≥2 (aOR 0.73, CI 0.54–0.98, p = 0.04), and major liver resection (aOR 0.50, CI 0.36–0.69, p < 0.001). After case-mix correction, no significant hospital or oncological network variation was observed.ConclusionTO differs between indications for liver resection and can be used to assess between hospital and network differences. 相似文献
6.
7.
8.
9.
美国食品药品管理局(FDA)于2022年7月发布了"治疗等效性评价供企业用指导原则"(草案)。该指导原则阐明了FDA治疗等效性的标准以及治疗等效性编码系统,目的是准确评价仿制药与参比制剂的治疗等效性并通过治疗等效性代码,在"橙皮书"中迅速检索到治疗等效的仿制药。而中国目前尚无类似的指导原则,详细介绍FDA该指导原则主要内容,期望对中国加强仿制药的治疗等效性评价和加速完善和实施符合国情的治疗等效性编码系统有所帮助。 相似文献
10.
目的 围绕足三里穴(ST36)进行文献可视化分析,探索近20年来有关足三里穴的研究进程、热点以及未来发展趋势。方法 以中国知网(CNKI)为数据来源,利用citespace软件对检索出的2000年1月至2021年11月收录的基础研究和临床研究文献分别进行可视化分析,绘制关键词、作者、机构相关图谱。结果 基础研究纳入1030篇文献,得到9个关键词聚类,电针中心度最高(0.53),发文量最多的作者是胡森(22篇),发文量最大的机构是北京中医药大学针灸推拿学院(23篇)。临床研究纳入2067篇文献,得到9个关键词聚类,穴位注射和针刺中心度最高(0.27),发文量最多的作者是张波(7篇),发文量最大的机构是浙江中医药大学附属第一医院(8篇)。结论 足三里穴在基础和临床的研究重点、热点和趋势不一致。并且在基础研究和临床研究之间,针刺镇痛、电针疗法、胃肠功能这三个内容是同步的,而关于代谢组学、穴位注射、温针灸和揿针的内容则是脱节的。 相似文献